• Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide.
• Hirotsu Y, Schmidt-Edelkraut U, Nakagomi H, Sakamoto I, Hartenfeller M, Narang R, Soldatos TG, Kaduthanam S, Wang X, Hettich S, Brock S, Jackson DB, Omata M.
• Int J Mol Sci. 2020 May 29;21(11):E3895. doi: 10.3390/ijms21113895.

• PMID: 32486089
• PubMed abstract
• Source abstract